Rett syndrome is now considered a possible treatable disorder based on the reversibility of neurological defects in Mecp2-deficient Rett syndrome model mice by the postnatal activation of MeCP2 expression (Guy et al., 2007; Lioy et al., 2011; Vashi and Justice, 2019). This evidence concerns the gene MECP2 and Rett syndrome.